Aerovate Therapeutics

$9.00 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest


About Aerovate Therapeutics

Aerovate Therapeutics Inc. operates as a biotechnology company. The Company focuses on developing drugs that improve the lives of patients with cardiopulmonary disease. Aerovate Therapeutics serves medical industry in the United States.

Stock Analysis

last close $9.09
1-mo return -2.1%
3-mo return -46.2%
avg daily vol. 39.37T
52-week high 29.43
52-week low 8.83
market cap. $232M
forward pe -
annual div. -
roe -
ltg forecast -
dividend yield -
annual rev. $--
inst own. -

Subscribe now for daily local and international financial news